후키파 파마(HOOK)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.15 (+0.88%), 시가총액 $0.01B, 52주 범위 $0.82 ~ $1.61.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer.
후키파 파마의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
후키파 파마의 현재 주가는 $1.15 (+0.88%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
후키파 파마의 시가총액은 약 $0.01B입니다.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology p